U.S. Markets closed

Cramer Weighs In On Biogen, Caterpillar And More

Craig Jones

Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Biogen Inc (NASDAQ: BIIB). He is concerned about the stock because a Baird analyst expressed his skepticism about Biogen's Alzheimer's drug.

Amgen, Inc. (NASDAQ: AMGN) is a much better company than it was six months ago, said Cramer. If it trades back to $210, he would be willing to buy it.

Cramer would sell some Caterpillar Inc. (NYSE: CAT) and buy it back at a lower price. He thinks the company isn't going to have a good quarter and he is worried about trade tariffs.

See Also: Can Tesla's Stock Continue Revving After 50% Rally?

ABIOMED, Inc. (NASDAQ: ABMD) has been de-risked and Cramer would buy the stock.

Northrop Grumman Corporation (NYSE: NOC) is cheap, said Cramer. He would start buying it within the next couple of days. He likes Lockheed Martin Corporation (NYSE: LMT) more.

Cramer would not buy Tegna (NYSE: TGNA). He thinks it's going to be possible to buy it later at a lower price.


See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.